Polar Asset Management Partners’s Myriad Genetics MYGN Stock Holding History

Polar Asset Management Partners’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-166,057	Closed	-$3.85M	–	944
2023 Q2	$3.85M	Hold	166,057	–	–	0.07%	352
2023 Q1	$3.86M	Sell	166,057 -106,300	-39%	-$2.16M	0.06%	397
2022 Q4	$3.95M	Sell	272,357 -702,800	-72%	-$13.1M	0.05%	491
2022 Q3	$18.6M	Sell	975,157 -204,900	-17%	-$4.7M	0.22%	103
2022 Q2	$21.4M	Buy	1,180,057 +1,063,020	+908%	+$22.1M	0.25%	81
2022 Q1	$2.95M	Buy	+117,037	New	+$3M	0.03%	559
2021 Q4	–	Sell	-591,000	Closed	-$19.1M	–	1428
2021 Q3	$19.1M	Buy	+591,000	New	+$19.6M	0.19%	124

Other funds holding MYGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Polar Asset Management Partners's MYGN Position: Q3 2023 in Review

Polar Asset Management Partners sold out of Myriad Genetics (MYGN) in Q3 2023, closing a stake of 166,057 shares — an estimated $3.85M sold.

Polar Asset Management Partners first reported a position in MYGN in Q3 2021 and held it in 7 quarters. The position peaked at $21.4M in Q2 2022. 186 funds tracked by Wall St. Rank hold MYGN as of Q3 2023.

Polar Asset Management Partners reported no remaining Myriad Genetics position as of Q3 2023 after selling out during the quarter.
Polar Asset Management Partners sold 166,057 Myriad Genetics shares in Q3 2023, an estimated $3.85M.
Polar Asset Management Partners first reported a position in Myriad Genetics in Q3 2021 and held it in 7 quarters.
Polar Asset Management Partners's Myriad Genetics position peaked at $21.4M in Q2 2022.
186 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2023.

Based on Polar Asset Management Partners's 13F filing for Q3 2023, filed 14 Nov 2023.